九天生物医药（上海）有限公司 Mediaroom - PR Newswire APAC

Search

九天生物医药（上海）有限公司

Latest News

Skyline Therapeutics' Novel Gene Therapy SKG1108 Receives FDA Orphan Drug Designation for Retinitis Pigmentosa

BOSTON and SHANGHAI, Sept. 3, 2024 /PRNewswire/ -- Skyline Therapeutics, an innovation-driven gene ...

2024-09-03 18:00 1062

Skyline Therapeutics Receives FDA Clearance of IND for SKG0106, a Novel Intravitreally Delivered AAV Gene Therapy Candidate for Neovascular Age-related Macular Degeneration

SHANGHAI and BOSTON, July 3, 2023 /PRNewswire/ -- Skyline Therapeutics, an innovation-driven gene t...

2023-07-03 19:00 1653

Skyline Therapeutics Brings Multiple Data Presentations to ASGCT 2023

SHANGHAI, May 17, 2023 /PRNewswire/ -- Skyline Therapeutics, an innovation-driven gene therapy comp...

2023-05-17 18:00 2075

Skyline Therapeutics to Present at the ASGCT 26th Annual Meeting

SHANGHAI, May 3, 2023 /PRNewswire/ -- Skyline Therapeutics, an innovation-driven gene therapy compa...

2023-05-03 12:00 1972